~~<i id='C9F7D5B9AA'><strike id='C9F7D5B9AA'><tt id='C9F7D5B9AA'><pre id='C9F7D5B9AA'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

leisure time

author：Wikipedia 2025-09-30 17:29:46 - browse：57129

Adam's take main illustration — Molly Ferguson/STAT

Biotech is awash in PIPEs.

The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Profiling embryos to choose those with higher IQs is almost a reality

hotspot

focus

Wikipedia

hotspot

CraigF.Walker/TheBostonGlobeAreviewofallegeddatamanipulationinstudiesinvolvingfourtopscientistsatDan

WSS

To bolster infectious disease surveillance, genomics powerhouses team up

Maisha Meds is a PBM, but don't call it that

Boston Scientific acquires urology company Axonics for $3.7 billion

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Merck to acquire Harpoon Therapeutics for $680 million

Immunocompromised patients offer clues on chronic Covid

knowledge

leisure time

hotspot

Medical leaders decry Supreme Court decision on affirmative action

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

State Dept. review finds Biden bears some blame for Afghanistan failures

Hospital chaplains balance Covid safety with patients’ spiritual needs

Psychedelics group wrestles with new pharma identity

Update the Apgar Score to remove skin color

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Medicare bonuses could stop drug shortages under Senate plan

Moonlake's readout produced a cash windfall. Risks remain

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

focus

Immunocompromised patients offer clues on chronic Covid

JPM pitch from hospitals? Revenue streams outside of patient care

Medicare drug price lawsuits could be good politics for Biden

What causes osteoarthritis? Researchers study link to brain protein

FDA endorses new sterilization method for medical devices

Mass General, Mayo Clinic look to monetize custom

focus

focus

Wikipedia

hotspot